Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

507 ARTÍCULOS , VIENDO DEL 421 AL 435

Resveratrol Reverses the Synaptic Plasticity Deficits in a Chronic Cerebral Hypoperfusion Rat Model

Li H, Wang J, Wang P, Rao Y, Chen L.

J Stroke Cerebrovasc Dis. 2016 Jan;25(1):122-8. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.004. Epub 2015 Oct 9.

Autobiographical memory for the differential diagnosis of cognitive pathology in aging

Meléndez JC, Redondo R, Torres M, Mayordomo T, Sales A.

Geriatr Gerontol Int. 2016 Nov;16(11):1220-1225. doi: 10.1111/ggi.12611. Epub 2015 Oct 13.

Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes

Raffield LM, Brenes GA, Cox AJ, Freedman BI, Hugenschmidt CE, Hsu FC, Xu J, Wagner BC, Williamson JD, Maldjian JA, Bowden DW.

J Diabetes Complications. 2016 Jan-Feb;30(1):143-9. doi: 10.1016/j.jdiacomp.2015.09.010. Epub 2015 Sep 25.

Therapeutic effects of dog visits in nursing homes for the elderly

Thodberg K, Sørensen LU, Christensen JW, Poulsen PH, Houbak B, Damgaard V, Keseler I, Edwards D, Videbech PB.

Psychogeriatrics. 2016 Sep;16(5):289-97. doi: 10.1111/psyg.12159. Epub 2015 Oct 29.

Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia

Bella R, Cantone M, Lanza G, Ferri R, Vinciguerra L, Puglisi V, Pennisi M, Ricceri R, Di Lazzaro V, Pennisi G.

Brain Stimul. 2016 Mar-Apr;9(2):225-33. doi: 10.1016/j.brs.2015.09.013. Epub 2015 Oct 9.

Performance of cognitive tests, individually and combined, for the detection of cognitive disorders amongst community-dwelling elderly people with memory complaints: the EVATEM study

Vannier-Nitenberg C, Dauphinot V, Bongue B, Sass C, Bathsavanis A, Rouch I, Deville N, Beauchet O, Krolak-Salmon P, Fantino B.

Eur J Neurol. 2016 Mar;23(3):554-61. doi: 10.1111/ene.12888. Epub 2015 Oct 30.

Phytoestrogen consumption and risk for cognitive decline and dementia: With consideration of thyroid status and other possible mediators

Soni M, White LR, Kridawati A, Bandelow S, Hogervorst E.

J Steroid Biochem Mol Biol. 2016 Jun;160:67-77. doi: 10.1016/j.jsbmb.2015.10.024. Epub 2015 Nov 1.

The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Xu W, Li JQ, Wang J, Lai TJ, Yu JT.

J Affect Disord. 2016 Jan 15;190:264-271. doi: 10.1016/j.jad.2015.09.069. Epub 2015 Oct 24.

Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial

Amieva H, Robert PH, Grandoulier AS, Meillon C, De Rotrou J, Andrieu S, Berr C, Desgranges B, Dubois B, Girtanner C, Joël ME, Lavallart B, Nourhashemi F, Pasquier F, Rainfray M, Touchon J, Chêne G, Dartigues JF.

Int Psychogeriatr. 2016 May;28(5):707-17. doi: 10.1017/S1041610215001830. Epub 2015 Nov 17.

Music therapy in patients with dementia and behavioral disturbance on an inpatient psychiatry unit: results from a pilot randomized controlled study

Thornley J, Hirjee H, Vasudev A.

Int Psychogeriatr. 2016 May;28(5):869-71. doi: 10.1017/S1041610215001866. Epub 2015 Nov 17.

Observational cohort study: deprivation and access to anti-dementia drugs in the UK

Cooper C, Lodwick R, Walters K, Raine R, Manthorpe J, Iliffe S, Petersen I.

Age Ageing. 2016 Jan;45(1):148-54. doi: 10.1093/ageing/afv154. Epub 2015 Nov 18.

Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment

Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A.

J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.

Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program

Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J.

Am J Psychiatry. 2016 Mar 1;173(3):252-62. doi: 10.1176/appi.ajp.2015.15010130. Epub 2015 Nov 20.

Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome

Wilcock DM, Schmitt FA, Head E.

Biochim Biophys Acta. 2016 May;1862(5):909-14. doi: 10.1016/j.bbadis.2015.11.007. Epub 2015 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias